Viewing Study NCT05020392


Ignite Creation Date: 2025-12-24 @ 3:27 PM
Ignite Modification Date: 2025-12-26 @ 3:07 PM
Study NCT ID: NCT05020392
Status: UNKNOWN
Last Update Posted: 2023-07-25
First Post: 2021-08-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Autologous Cells Derived Anti-CD19 CAR-Engineered T Cells With Concurrent BTK Inhibitor for B Cell Lymphoma
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module